Regeneron Pharmaceuticals | Ventes



Sales Changement Date
AbbVie USD 15.42B 2.08B 2025-06
Agios Pharmaceuticals USD 12.45M 3.75M 2025-06
Alnylam Pharmaceuticals USD 773.69M 179.5M 2025-06
Amgen USD 8.15B 936M 2025-03
Astellas Pharma JPY 505.79B 46.5B 2025-06
AstraZeneca USD 14.46B 867M 2025-06
Biogen USD 2.6B 170M 2025-06
BioMarin Pharmaceutical USD 745M 2.31M 2025-03
Bristol-Myers Squibb USD 12.27B 1.07B 2025-06
Eli Lilly USD 12.73B 802.8M 2025-03
Gilead Sciences USD 6.67B 899M 2025-03
GlaxoSmithKline GBP 7.99B 470M 2025-06
Incyte USD 1.06B 10M 2025-06
Ionis Pharmaceuticals USD 452M 320M 2025-06
J&J USD 23.74B 1.85B 2025-06
Kyowa Hakko Kirin JPY 104.73B 28.03B 2025-03
Merck USD 15.81B 280M 2025-06
Moderna USD 108M 858M 2025-03
Neurocrine Biosciences USD 687.5M 114.9M 2025-06
Novartis USD 14.05B 821M 2025-06
Novartis USD 13.56B 386M 2024-12
Pfizer USD 13.72B 4.04B 2025-03
Regeneron Pharmaceuticals USD 3.03B 760M 2025-03
Roche Holding CHF 31.64B 883M 2024-12
Sanofi EUR 11.26B 3.5B 2024-12
Sarepta Therapeutics USD 774.9M 116.49M 2025-03
Teva Pharmaceutical Industries USD 14.06B 0 2025-06
Ultragenyx Pharmaceutical USD 139.29M 25.59M 2025-03
United Therapeutics USD 798.6M 4.2M 2025-06
Vertex Pharmaceuticals USD 2.77B 142M 2025-03


Regeneron Pharmaceuticals Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.